Suppr超能文献

一例表现为肢端肥大症的鞍内垂体腺瘤-神经节细胞瘤。

An intrasellar pituitary adenoma-gangliocytoma presenting as acromegaly.

作者信息

Lee Melissa H, McKelvie Penelope, Krishnamurthy Balasubramanian, Wang Yi Yuen, Caputo Carmela

机构信息

Departments of Endocrinology and Diabetes.

Departments of Anatomical Pathology, St Vincent's Hospital Melbourne, VictoriaAustralia.

出版信息

Endocrinol Diabetes Metab Case Rep. 2017 Apr 27;2017. doi: 10.1530/EDM-17-0035. eCollection 2017.

Abstract

UNLABELLED

Most cases of acromegaly are due to growth hormone (GH)-secreting pituitary adenomas arising from somatotroph cells. Mixed pituitary adenoma and gangliocytoma tumours are rare and typically associated with hormonal hypersecretion, most commonly GH excess. Differentiating these mixed tumours from conventional pituitary adenomas can be difficult pre-operatively, and careful histological analysis after surgical resection is key to differentiating the two entities. There is little literature addressing the possible mechanisms for the development of mixed pituitary adenoma-gangliocytomas; however, several hypotheses have been proposed. It still remains unclear if these mixed tumours differ from a clinical perspective to pituitary adenomas; however, the additional neural component of the gangliocytoma does not appear to modify the aggressiveness or risk of recurrence after surgical resection. We report a unique case of acromegaly secondary to a mixed GH-secreting pituitary adenoma, co-existing with an intrasellar gangliocytoma.

LEARNING POINTS

Acromegaly due to a mixed GH-secreting pituitary adenoma and intrasellar gangliocytoma is rare.These mixed tumours cannot be distinguished easily from ordinary pituitary adenomas on the basis of clinical, endocrine or neuroradiologic findings, and histological analysis is required for a definitive diagnosis.Surgical resection is usually sufficient to provide cure, without the need for adjuvant therapy.These mixed tumours appear to have a good prognosis although the natural history is not well defined.The pathogenesis of these mixed tumours remains debatable, and ongoing research is required.

摘要

未标注

大多数肢端肥大症病例是由于生长激素(GH)分泌型垂体腺瘤,起源于生长激素细胞。混合性垂体腺瘤和神经节细胞瘤很罕见,通常与激素分泌过多有关,最常见的是生长激素过量。术前很难将这些混合性肿瘤与传统垂体腺瘤区分开来,手术切除后进行仔细的组织学分析是区分这两种实体的关键。关于混合性垂体腺瘤-神经节细胞瘤发生发展的可能机制的文献很少;然而,已经提出了几种假说。从临床角度来看,这些混合性肿瘤是否与垂体腺瘤不同仍不清楚;然而,神经节细胞瘤额外的神经成分似乎并未改变手术切除后的侵袭性或复发风险。我们报告了一例独特的肢端肥大症病例,继发于分泌生长激素的混合性垂体腺瘤,同时合并鞍内神经节细胞瘤。

学习要点

由分泌生长激素的混合性垂体腺瘤和鞍内神经节细胞瘤引起的肢端肥大症很罕见。这些混合性肿瘤在临床、内分泌或神经放射学检查结果的基础上,很难与普通垂体腺瘤区分开来,明确诊断需要组织学分析。手术切除通常足以治愈,无需辅助治疗。尽管其自然病史尚不明确,但这些混合性肿瘤似乎预后良好。这些混合性肿瘤的发病机制仍有争议,需要持续研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4a2/5409941/06097b340c35/edmcr-2017-170035-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验